
About Dr. Shaheenah Dawood
Dr. Shaheenah Dawood is a highly experienced Medical Oncologist with over 26 years of clinical and academic experience. She specialises in the treatment of breast cancer, gastrointestinal cancers, and targeted cancer therapies.
Dr. Dawood provides personalised treatment plans based on each patient's condition, using the latest advances in genomic testing and precision medicine. She is committed to offering high-quality cancer care while supporting patients and their families throughout their treatment journey.
Why Choose Dr. Shaheenah Dawood?
- International Training: Completed her medical oncology training at McGill University Hospitals, Canada, and received advanced breast cancer training through the Susan G. Komen Breast Cancer Fellowship at MD Anderson Cancer Centre, USA.
- Leader in Clinical Research: Heads the oncology clinical trials programme at Mediclinic City Hospital, giving patients access to the latest cancer treatments. She has also published over 100 research papers.
- Recognised Oncology Leader: Serves as the President of the Excellence in Oncology Care (EIOC) Congress and Co-President of the Asia Pacific Breast Cancer Summit (APBCS).
- Expert in Personalised Cancer Care: Uses genomic testing, immunotherapy, and targeted therapies to create treatment plans tailored to each patient's needs.
- Award-Winning Specialist: Received the Top Emirati Contributor Award from the Dubai Healthcare City Authority and several ASCO Merit Awards for her contributions to cancer research and patient care.
- Top Emirati Contributor Award – Dubai Healthcare City Authority (DHCA) Regulatory Excellence Awards (2020)
- ASCO Merit Awards – Awarded by the American Society of Clinical Oncology during her medical training
- Scholar-in-Training Awards – Recognised for exceptional academic merit during her clinical oncology residency and fellowship
- Editorial Fellowship – The New England Journal of Medicine
Papers Published
Dr. Dawood has over 100 publications to her credit (including 50+ peer-reviewed original articles and 12 book chapters). A selection of her most significant works include:
+ Read More- Show Less
- Monitoring and management of adverse effects associated with trastuzumab deruxtecan: a UAE-specific consensus – Frontiers in Oncology (2025)
- Impact of the Latest Clinical Data among Patients with Breast Cancer in Low- and Middle-Income Countries – Breast Care (2022)
- Optimizing the management of HER2-negative metastatic breast cancer in the era of PARP inhibitors (2020)
- Androgen receptor expression and breast cancer survival in postmenopausal women – Clinical Cancer Research (2011)
- Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study – Breast Cancer Research and Treatment (2011)
- Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review – Journal of Clinical Oncology (2010)
- Biology and management of inflammatory breast cancer – Expert Review of Anticancer Therapy (2010)
Send Your Enquiry
Fill in your details and our medical experts will contact you within 24 hours.
Want to consult the doctor?
Don't Ignore Your Health!
Other Top Medical Oncologist In Dubai


Dr. Ed Ashtar

Dr. Hassan Ghazal

